Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with stakeholders on the efficacy of pancreatic enzyme replacement therapy as a treatment option for patients diagnosed with pancreatic cancer.
The National Health Service continues to work with Pancreatic Cancer UK to raise awareness of prescribed pancreatic enzyme replacement therapy (PERT), including sharing guidance with Cancer Alliances. The National Institute for Health and Care Excellence’s guidelines recommend that PERT should be considered for people with both operable and inoperable pancreatic cancer.